HIT Consultant June 7, 2024
What You Should Know:
– Helix, a leader in population genomics, is launching new datasets designed to empower life science companies in developing precision medicine therapies.
– These comprehensive datasets, built through collaborations with various health systems, provide researchers with a rich resource for drug discovery and development across multiple disease areas.
Unveiling the Power of Clinico-Genomic Data
The datasets offer a unique combination of longitudinal clinical data and genomic information. This includes extensive medical records spanning a patient’s healthcare journey, along with their genetic makeup. The data covers a wide range of therapeutic areas, including:
- Cardiovascular diseases
- Immunological and inflammatory conditions
- Metabolic disorders
Precision Cohorts for Targeted Research
Helix’s approach leverages “precision cohorts,” meticulously curated...
Today's Sponsors
Today's Sponsor